Revised Protocol 0302-Dec-2018•The eligibility criteria was modified to include additional tumor types, including but not limited to Cervical Cancer (CC), Melanoma (MEL), Renal Cell Carcinoma (RCC) and Triple Negative Breast Cancer (TNBC). •The eligibility criteria was modified to allow for up to three prior lines of systemic therapy.